Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Dyne Therapeutics, Inc. (DYN)  
$30.94 1.57 (4.83%) as of 4:30 Fri 6/7


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 81,110,000
Market Cap: 2.51(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $6.62 - $35.38
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 21.5
Insider 3/6 Months : 22.1
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Dyne Therapeutics is a muscle disease company focused on developing therapeutics for people living with genetically driven diseases. Co. is developing the following product candidates: DYNE-101, to address the genetic basis of myotonic dystrophy type 1 by targeting the toxic nuclear DMPK RNA that causes the disease; DYNE-251 for patients with mutations amenable to skipping Exon 51, to be followed by the development of therapeutics for patients with mutations amenable to skipping other exons, including Exon 53, 45 and 44; and DYNE-301 to address the genetic basis of facioscapulohumeral dystrophy by reducing DUX4 expression in muscle tissue.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 1,714,285 1,714,285 3,583,447
Total Buy Value $0 $29,999,988 $29,999,988 $50,000,022
Total People Bought 0 1 1 3
Total Buy Transactions 0 1 1 3
Total Shares Sold 139,260 5,065,359 5,434,480 5,751,795
Total Sell Value $3,826,508 $120,434,827 $125,003,319 $128,995,680
Total People Sold 6 9 9 9
Total Sell Transactions 13 75 98 109
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 222
  Page 1 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cox John CEO & President   •       •      –    2024-03-25 3/A IO $0.00 $0 D/D 0 5,000     -
   Cox John See Remarks   •       •      –    2024-03-25 3 IO $0.00 $0 D/D 0 10,000 25%     
   Farwell Wildon Chief Medical Officer   •       –      –    2024-03-12 4 AS $25.58 $26,347 D/D (1,030) 150,560 14%     
   Mcneill Jonathan Chief Business Officer   •       –      –    2024-03-11 4 AS $25.48 $499,842 D/D (19,601) 139,408 21%     
   Mcneill Jonathan Chief Business Officer   •       –      –    2024-03-11 4 OE $5.54 $98,751 D/D 17,825 159,009     -
   High Susanna Gatti Chief Operating Officer   •       –      –    2024-03-11 4 AS $25.70 $58,904 D/D (2,292) 156,800 21%     
   Farwell Wildon Chief Medical Officer   •       –      –    2024-03-11 4 AS $25.70 $40,735 D/D (1,585) 151,590 21%     
   Brumm Joshua T CEO & President   •       •      –    2024-03-11 4 AS $25.42 $1,704,142 D/D (66,387) 537,998 21%     
   Brumm Joshua T CEO & President   •       •      –    2024-03-11 4 OE $5.54 $277,000 D/D 50,000 604,385     -
   Scalzo Richard William SVP, Head of Finance & Admin.   •       –      –    2024-03-11 4 AS $24.99 $67,542 D/D (2,672) 119,283 21%     
   Beskrovnaya Oxana Chief Scientific Officer   •       –      –    2024-03-11 4 AS $25.70 $53,482 D/D (2,081) 152,352 21%     
   Mcneill Jonathan Chief Business Officer   •       –      –    2024-03-08 4 AS $25.46 $2,361,531 D/D (90,000) 141,184 23%     
   Mcneill Jonathan Chief Business Officer   •       –      –    2024-03-08 4 OE $5.54 $498,600 D/D 90,000 231,184     -
   High Susanna Gatti Chief Operating Officer   •       –      –    2024-03-08 4 AS $26.66 $725,344 D/D (27,199) 159,092 23%     
   Brumm Joshua T CEO & President   •       •      –    2024-03-08 4 AS $25.30 $9,421,634 D/D (363,343) 554,385 23%     
   Brumm Joshua T CEO & President   •       •      –    2024-03-08 4 OE $5.54 $2,012,920 D/D 363,343 917,728     -
   Scalzo Richard William SVP, Head of Finance & Admin.   •       –      –    2024-03-08 4 AS $25.31 $2,261,465 D/D (86,252) 121,955 23%     
   Scalzo Richard William SVP, Head of Finance & Admin.   •       –      –    2024-03-08 4 OE $5.54 $477,836 D/D 86,252 208,207     -
   Farwell Wildon Chief Medical Officer   •       –      –    2024-03-07 4 AS $25.80 $256,585 D/D (9,921) 153,175 17%     
   High Susanna Gatti Chief Operating Officer   •       –      –    2024-03-07 4 AS $25.85 $41,127 D/D (1,591) 186,291 17%     
   Brumm Joshua T CEO & President   •       •      –    2024-03-07 4 AS $25.85 $234,873 D/D (9,086) 554,385 17%     
   Beskrovnaya Oxana Chief Scientific Officer   •       –      –    2024-03-07 4 AS $25.85 $61,342 D/D (2,373) 154,433 17%     
   Scalzo Richard William SVP, Head of Finance & Admin.   •       –      –    2024-03-07 4 AS $25.85 $58,757 D/D (2,273) 121,955 17%     
   Mcneill Jonathan Chief Business Officer   •       –      –    2024-03-07 4 AS $25.85 $62,919 D/D (2,434) 141,184 17%     
   Rhodes Jason P   –       •      –    2024-03-01 4 AS $30.05 $1,398,347 I/I (46,534) 847,388 6%     
  222 Records found
  1  2  3  4  5  6  7  8  9   
  Page 1 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us